Reprogramming tumour-associated macrophages in breast cancer via si-FOXM1-loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy. - Gao Y; Li J; Xu M; Liu Y; Guo L (British journal of pharmacology, 2026)